May 30, 2014 - Endomedix receives SBIR Grant


Newark, NJ – May 30, 2014 Endomedix, Inc. announced today that the National Institute of Neurological Disorders and Stroke (NINDS) has awarded it a Phase II Small Business Innovation Research (SBIR) grant. NINDS is one of the 27 institutes and centers of the NIH. The grant, (Award Number 2R44NS070331-02A1) with a value of $1,491,256 and titled Hemorrhage Control during Brain Surgery, will support the Company’s program to develop a fast acting, biocompatible surgical hemostat intended for use in intracranial surgery.


See PDF attachement below for full release.

Last Updated on Tuesday, 03 June 2014 13:20